JP Morgan Chase
ELGX

JP Morgan Chase’s Endologix Inc ELGX Stock Holding History

JP Morgan Chase’s Portfolio ELGX Stock Details ELGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-18,168
Closed -$15K – 6042
2020
Q2 		$15K Hold
18,168
– – ﹤0.01% 5082
2020
Q1 		$13K Sell
18,168
-36,044
-66% -$44.1K ﹤0.01% 5024
2019
Q4 		$86K Sell
54,212
-65,851
-55% -$184K ﹤0.01% 4959
2019
Q3 		$477K Buy
120,063
+5,295
+5% +$30.8K ﹤0.01% 4199
2019
Q2 		$838K Buy
114,768
+102,807
+860% +$701K ﹤0.01% 3961
2019
Q1 		$79K Sell
11,961
-76,053
-86% -$501K ﹤0.01% 4964
2018
Q4 		$630K Buy
88,014
+83,630
+1,908% +$931K ﹤0.01% 4014
2018
Q3 		$84K Buy
4,384
+2,057
+88% +$73.4K ﹤0.01% 5017
2018
Q2 		$132K Buy
2,327
+33
+1% +$1.67K ﹤0.01% 4742
2018
Q1 		$97K Sell
2,294
-2,996
-57% -$129K ﹤0.01% 4600
2017
Q4 		$283K Sell
5,290
-5,648
-52% -$298K ﹤0.01% 4292
2017
Q3 		$488K Buy
10,938
+7,423
+211% +$338K ﹤0.01% 3839
2017
Q2 		$171K Sell
3,515
-2,524
-42% -$149K ﹤0.01% 4034
2017
Q1 		$438K Buy
6,039
+2,102
+53% +$139K ﹤0.01% 3772
2016
Q4 		$225K Buy
3,937
+640
+19% +$58.6K ﹤0.01% 4135
2016
Q3 		$422K Buy
3,297
+61
+2% +$7.81K ﹤0.01% 3459
2016
Q2 		$403K Buy
3,236
+809
+33% +$93K ﹤0.01% 3519
2016
Q1 		$203K Sell
2,427
-8
-0.3% -$659 ﹤0.01% 3617
2015
Q4 		$241K Buy
+2,435
New +$261K ﹤0.01% 3606
2015
Q3 		– Sell
-28,348
Closed -$4.35M – 4182
2015
Q2 		$4.35M Buy
28,348
+11,061
+64% +$1.83M ﹤0.01% 2472
2015
Q1 		$2.95M Buy
17,287
+13,547
+362% +$2.05M ﹤0.01% 2664
2014
Q4 		$572K Buy
+3,740
New +$467K ﹤0.01% 3610
2013
Q4 		– Sell
-1,872
Closed -$302K – 4341
2013
Q3 		$302K Sell
1,872
-4,423
-70% -$697K ﹤0.01% 3869
2013
Q2 		$836K Buy
+6,295
New +$889K ﹤0.01% 3363

Other funds holding ELGX

WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

JP Morgan Chase's ELGX Position: Q3 2020 in Review

JP Morgan Chase sold out of Endologix Inc (ELGX) in Q3 2020, closing a stake of 18,168 shares — an estimated $15K sold.

JP Morgan Chase first reported a position in ELGX in Q2 2013 and held it in 24 quarters. The position peaked at $4.35M in Q2 2015. 6 funds tracked by Wall St. Rank hold ELGX as of Q3 2020.

  • JP Morgan Chase reported no remaining Endologix Inc position as of Q3 2020 after selling out during the quarter.
  • JP Morgan Chase sold 18,168 Endologix Inc shares in Q3 2020, an estimated $15K.
  • JP Morgan Chase first reported a position in Endologix Inc in Q2 2013 and held it in 24 quarters.
  • JP Morgan Chase's Endologix Inc position peaked at $4.35M in Q2 2015.
  • 6 funds tracked by Wall St. Rank held Endologix Inc as of Q3 2020.

Based on JP Morgan Chase's 13F filing for Q3 2020, filed 12 Nov 2020.